Clinical research plays a pivotal role in advancing medical breakthroughs and improving patient care. In an industry where precision and efficiency are paramount, Avance Clinical has emerged as a leading Contract Research Organization (CRO) dedicated to transforming the landscape of clinical trials. With its unwavering commitment to excellence and innovative approach, Avance Clinical is a proven and trusted partner for biotech companies worldwide.
Avance Clinical is also at the cutting edge of clinical trial technology and has recently been ranked as the world leader in DCT technology adoption by GlobalData and Clinical Trial Arena in the CRO sector. The report found 46% of Avance Clinical’s trials incorporated some elements of DCT technologies in 2022 including telemedicine, remote monitoring, and digital data collection.
The DCT report also noted that Avance Clinical’s staff training in the latest technologies was a key factor in the ranking. See the full report here
Headquartered in Australia, Avance Clinical has positioned itself as a global leader in early to later phase clinical research. The company's success can be attributed to its unique blend of scientific expertise, cutting-edge technology, and an agile client-centric approach.
Avance Clinical understands the challenges faced by its biotech partners in bringing new treatments to market and provides tailored solutions to meet their specific needs.
In 2022 Avance Clinical expanded its geographic footprint and acquired a CRO partner in North America which supports clients move from early to late phase trials through their GlobalReady program. It also means clients get the same high-quality CRO team in Australia, New Zealand and the US as well as reducing the time and cost of studies. The process delivers quality FDA-accepted data in a program that has so far been utilised by more than 50 biotech clients.
One of Avance Clinical's key strengths lies in its scientific expertise. The company boasts a team of highly qualified professionals, including leading experts in their respective therapeutic areas. This deep knowledge allows Avance Clinical to design and execute clinical trials rapidly and cost effectively while producing the very best quality data. Avance Clinical’ experience enables it to maximize the chances of success for its clients' drug development programs.
In addition to its scientific excellence, Avance Clinical embraces technological innovation to streamline and optimize clinical trial processes. The company employs state-of-the-art technologies and data management systems, enabling efficient data capture, analysis, and reporting. By leveraging advanced analytics and real-time data insights, Avance Clinical empowers its clients to make data-driven decisions, accelerate timelines, and reduce costs. This commitment to cutting-edge technology sets Avance Clinical apart from its competitors and positions it at the forefront of the industry.
Avance Clinical's client-centric approach is another hallmark of its success. The company understands that each client is unique, with specific goals, timelines, and budgetary considerations. Therefore, Avance Clinical works closely with its partners to develop customized strategies that align with their individual objectives. This collaborative approach fosters strong relationships and ensures seamless communication throughout the trial process. Clients appreciate the high level of transparency and responsiveness provided by Avance Clinical, which further strengthens their trust in the organization.
Furthermore, Avance Clinical's Australian operations offers a strategic edge for its clients. Australia is recognized globally for its high regulatory standards, robust healthcare infrastructure, diverse patient population, attractive tax rebate of 43.5%, and rapid approval processes. By partnering with Avance Clinical, biotech companies gain access to a favourable clinical research environment, reducing risks and accelerating their time to market.
The company's impressive track record speaks for itself. Avance Clinical has successfully completed studies across a wide range of therapeutic areas, including oncology, neurology, cardiology, and infectious diseases. Its portfolio includes collaborations with both small biotech start-ups and large established biotech companies.
Avance Clinical's ability to deliver high-quality results on time and within budget has earned it a global leadership position in the biotech sector.
